Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 68788-8769

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 68788-8769). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion HCl Extended-release Tab Sr 150mg (Bupropionhcl150mg60scont)

Label for Bupropion HCl Extended-Release Tablet (SR) 150 mg, a generic version of Wellbutrin SR, manufactured by Annora Pharma Pvt. Ltd. The label includes directions for use in English and Spanish on a yellow background, cautionary statements about storage and use, and the manufacturer’s logo and address. The product is an oral extended-release tablet with lot, batch, and expiration date fields.*

FDA Label Image

Bupropionhclstructure (Bupropionhclstructure)

Chemical structure of bupropion hydrochloride showing the molecular arrangement including a chlorophenyl group, a ketone group, and a hydrochloride salt component, consistent with the active ingredient in the Bupropion hydrochloride extended-release tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.